| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 18 | +33.33% | +4.93% | -1.56% | +6.49% | +5.26% | — |
| 14d | 18 | +44.44% | +8.69% | -1.17% | +9.86% | +7.65% | — |
| 30d | 18 | +50.00% | -7.01% | -1.25% | -5.76% | -2.23% | — |
| 60d | 18 | +77.78% | -2.48% | -1.77% | -0.72% | -15.68% | — |
| 90d | 18 | +94.44% | -3.70% | -1.96% | -1.74% | -18.53% | — |
| 180d | 18(1 pending) | +94.12% | -28.04% | -4.58% | -23.46% | -38.59% | — |
| 1y | 18(1 pending) | +94.12% | -15.80% | -2.02% | -13.79% | -46.37% | — |
| 2y | 18(2 pending) | +100.00% | -90.29% | +9.78% | -100.07% | -96.56% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CTMX CYTOMX THERAPEUTICS, INC. | SALE Chief Medical Officer | 21,279 | $6.42 | $136.7K | 189,446 | Mar 17, 2026 | Mar 19, 2026 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 210,725 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 87,500 | — | — | 87,500 | Sep 26, 2025 | Sep 30, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 43,750 | — | — | 43,750 | Sep 26, 2025 | Sep 30, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,025 | $0.60 | $2.4K | 135,725 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 115,000 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 57,500 | — | — | 139,750 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 56,000 | — | — | 82,250 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 238,000 | — | — | 238,000 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jan 18, 2024 | Jan 22, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,250 | — | — | 26,250 | Jan 18, 2024 | Jan 22, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 122,500 | — | — | 122,500 | Jan 18, 2024 | Jan 22, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 375,000 | — | — | 375,000 | Jul 19, 2023 | Jul 20, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE10b5-1 10b5-1 plan | 2,317 | $6.58 | $15.2K | 140,676 | Apr 18, 2023 | Apr 19, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE10b5-1 10b5-1 plan | 215 | $6.52 | $1.4K | 142,993 | Apr 18, 2023 | Apr 19, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 425,000 | — | — | 425,000 | Feb 6, 2023 | Feb 7, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Chief Medical Officer | 7,825 | $5.24 | $41.0K | 143,208 | Jan 10, 2023 | Jan 11, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Chief Medical Officer | 4,062 | $35.37 | $143.7K | 151,033 | Apr 19, 2022 | Apr 21, 2022 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 53,058 | — | — | 53,058 | Jan 25, 2022 | Jan 27, 2022 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 33,302 | — | — | 155,095 | Jan 25, 2022 | Jan 27, 2022 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 418 | $49.10 | $20.5K | 121,793 | Jan 11, 2022 | Jan 13, 2022 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 3,547 | $48.44 | $171.8K | 122,211 | Jan 11, 2022 | Jan 13, 2022 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 5 | $55.54 | $278 | 125,758 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 1,045 | $51.08 | $53.4K | 129,216 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 2,097 | $49.32 | $103.4K | 131,161 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 600 | $54.58 | $32.7K | 126,763 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 900 | $50.42 | $45.4K | 130,261 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 1,031 | $53.66 | $55.3K | 126,363 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 1,822 | $52.37 | $95.4K | 127,394 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 7,500 | — | — | 105,000 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASE Senior VP Clinical Development | 7,500 | $16.32 | $122.4K | 133,258 | Dec 10, 2021 | Dec 13, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 60,958 | — | — | 125,758 | Nov 19, 2021 | Nov 22, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 875 | $81.80 | $71.6K | 67,200 | Apr 16, 2021 | Apr 20, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 1,500 | $84.41 | $126.6K | 64,800 | Apr 16, 2021 | Apr 20, 2021 ↗ | View → |
| FATE FATE THERAPEUTICS INC | SALE Senior VP Clinical Development | 900 | $82.91 | $74.6K | 66,300 | Apr 16, 2021 | Apr 20, 2021 ↗ | View → |